Evaluation of Speech and Voice Biomarkers in Association With Burnout

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
Minneapolis Heart Institute Foundation
Study ID
NCT07780812
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Burnout
  • Burnout, Healthcare Workers

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Calmigo — DEVICE
    use of the calmigo device 3 times a day for 3 minutes at a time across 12 weeks

Study Details

This project aims to explore how speech patterns and voice characteristics can be used to detect signs of burnout and stress in physicians.

Key Dates

First listed
Aug 24, 2026
Start date
Jun 2, 2025
Status verified
Aug 2026
Primary completion
Jun 2, 2027
Completion
Oct 2, 2027

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Intervention Arm
    Calmigo device
  • No Intervention: No intervention
    no intervention

Primary Outcome Measure

Mini-Z 2.0 survey score [ Time Frame: 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Minneapolis Heart InstituteMinneapolisMinnesota55407
Michaella Alexandrou, MD
[email protected]
612-863-4768

Find similar trials in Minneapolis, MN

By research site
Minneapolis Heart Institute· Minneapolis, MN

Related Studies